Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, Irvine
Centre Hospitalier Universitaire Vaudois
NRG Oncology
NRG Oncology
National Taiwan University Hospital
International Agency for Research on Cancer
Mayo Clinic
NRG Oncology
Inhibrx Biosciences, Inc
University of Wisconsin, Madison
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
University of Massachusetts, Boston
Centre Oscar Lambret
Centre Oscar Lambret
Vanderbilt-Ingram Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
Emory University
Centre Francois Baclesse
Wake Forest University Health Sciences
University of Washington
University of Pisa
UNC Lineberger Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Milton S. Hershey Medical Center
Memorial Sloan Kettering Cancer Center
Centre Georges Francois Leclerc
Case Comprehensive Cancer Center
University of California, San Diego
M.D. Anderson Cancer Center
Emory University